Pacira | PCRX - EPS Earnings Per Share


Pacira reported $0.06 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.73 0.62 Apr/30
FY2025Q4 Dec/2025 0.91 0.91 Feb/26
FY2025Q3 Sep/2025 0.70 0.66 0.79 Nov/06
FY2025Q2 Jun/2025 0.74 0.68 0.89 Aug/05
FY2025Q1 Mar/2025 0.62 0.61 0.62 May/08




Eps Change Date
Assertio Holdings USD -0.03 0.01 Sep/2024
Astellas Pharma JPY 24.29 31.75 Mar/2026
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Cara Therapeutics USD -0.59 4.45 Sep/2025
Coherus Biosciences USD -0.43 0.06 Dec/2025
Heron Therapeutics USD -0.02 0.02 Dec/2025
Ironwood Pharmaceuticals USD -0.01 0.25 Dec/2025
J&J USD 2.7 0.24 Mar/2026
Ligand Pharmaceuticals USD 2.02 1.07 Dec/2025
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Novo Nordisk DKK 6.04 1.54 Dec/2025
Omeros USD -1.12 0.37 Jun/2024
Pacira USD 0.06 0.64 Dec/2025
Perrigo USD 0.77 0.03 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
Supernus Pharmaceuticals USD -0.07 0.73 Dec/2025
Teva Pharmaceutical Industries USD 2.98 0.43 Dec/2025
Xeris Pharmaceuticals USD 0.05 0.05 Dec/2025
Xoma USD -1.59 2.43 Sep/2024
Zoetis USD 1.48 0.22 Dec/2025